| Identification | Back Directory | [Name]
1-ethyl-2-[(E)-2-(furan-2-yl)ethenyl]benzimidazole | [CAS]
685097-43-2 | [Synonyms]
WAY-323879
1-ethyl-2-[(E)-2-(furan-2-yl)ethenyl]benzimidazole
1H-Benzimidazole, 1-ethyl-2-[2-(2-furanyl)ethenyl]- | [Molecular Formula]
C15H14N2O | [MOL File]
685097-43-2.mol | [Molecular Weight]
238.28 |
| Chemical Properties | Back Directory | [Boiling point ]
416.4±48.0 °C(Predicted) | [density ]
1.13±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
5.30±0.10(Predicted) | [color ]
Light brown to brown |
| Hazard Information | Back Directory | [Uses]
SNX7 is a Cyclin-Dependent Kinase Inhibitor (CDKI) pathway inhibitor. SNX7 can be used for research of senescence-related and other CDKI-related diseases[1]. | [References]
[1] Bey-Dih Chang, et al. Cdki pathway inhibitors and uses thereof. Patent. US20090281129. |
|
|